The man reinventing a trillion-dollar drugmaker

单集文稿 ...

• 00:14

  The Economist.

• 00:23

  Established 150 years ago, the pharma giant Eli Lilly

• 00:27

  has seen wonder drugs come and go.

• 00:30

  Indispensable to every position are the remarkable new medicines recently developed.

• 00:35

  The sulfur drugs and such other antibiotics as penicillin and streptomycin.

• 00:41

  Today's miracle cures are the obesity busting GLP-1s.

• 00:46

  In the span of just a few short years,

• 00:48

  weight loss jabs like Wegovy and Mounjaro have become so prevalent in our culture,

• 00:54

  transforming the way we live, move, and eat.

• 00:57

  With Wegovy and Ozempic, Novo Nordisk had an early lead in this field.

• 01:03

  But Eli Lilly's drugs, Mounjaro and Zepbound, have recently surged in popularity,

• 01:10

  helping the company to eclipse its old rival.

• 01:13

  Eli Lilly hit $1 trillion in market value on Friday,

• 01:17

  making it the first drug maker to enter an exclusive club

• 01:21

  dominated by tech giants and underscoring its rise as a weight loss powerhouse.

• 01:27

  So today, how did Eli Lilly become the world's most valuable healthcare company?

• 01:41

  You're listening to Money Talks from The Economist,

• 01:43

  our weekly podcast on the markets, the economy and the world of business.

• 01:47

  In London, I'm Alice Fulwood.

• 01:49

  In New York, I'm Mike Bird.

• 全部文稿